| P2093 | author name string | Jinhua Lu | |
| | Uday Kishore | |
| P2860 | cites work | An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development | Q24298379 |
| | Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation | Q24299377 |
| | Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q | Q24309368 |
| | The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties | Q24320322 |
| | Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes | Q24337767 |
| | Human genes for complement components C1r and C1s in a close tail-to-tail arrangement | Q24647917 |
| | C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells | Q24670661 |
| | Macrophage heterogeneity in tissues: phenotypic diversity and functions | Q26861223 |
| | Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 |
| | Complement. First of two parts | Q28210663 |
| | Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 |
| | Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype | Q28238306 |
| | The classical complement cascade mediates CNS synapse elimination | Q28261273 |
| | Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits | Q28276981 |
| | Augmented Wnt signaling in a mammalian model of accelerated aging | Q28506533 |
| | Interferon and granulopoiesis signatures in systemic lupus erythematosus blood | Q29615064 |
| | Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis | Q29619965 |
| | Apoptosis: controlled demolition at the cellular level | Q29620114 |
| | Enhanced synaptic connectivity and epilepsy in C1q knockout mice | Q30494456 |
| | Maturation of dendritic cells abrogates C1q production in vivo and in vitro | Q75272880 |
| | Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon | Q77111618 |
| | The significance of the lupus globulin; nucleoprotein reaction | Q78367789 |
| | Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis | Q79106760 |
| | Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue | Q79871619 |
| | Common silent mutations in all types of hereditary complement C1q deficiencies | Q81019615 |
| | Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus | Q81129128 |
| | Immune modulation of human dendritic cells by complement | Q81360867 |
| | C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation | Q83689744 |
| | Complement C1q production by osteoclasts and its regulation of osteoclast development | Q84588704 |
| | C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis | Q84596359 |
| | Serum C1q as a novel biomarker of sarcopenia in older adults | Q86221304 |
| | Elucidation of the substrate specificity of the C1s protease of the classical complement pathway | Q33223538 |
| | The key role of nucleosomes in lupus | Q33633300 |
| | Systemic lupus erythematosus, complement deficiency, and apoptosis | Q34082803 |
| | Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus | Q34224780 |
| | The ancestral complement system in sea urchins | Q34286998 |
| | Proteases of the complement system | Q34293205 |
| | Advances in lupus genetics and epigenetics | Q34464114 |
| | Genome duplication, extinction and vertebrate evolution | Q34526190 |
| | Evolution of enzyme cascades from embryonic development to blood coagulation | Q34536452 |
| | Phagocytosis of microbes: complexity in action | Q34542300 |
| | Steady-state and inflammatory dendritic-cell development | Q34591334 |
| | C1q and its growing family. | Q34633739 |
| | C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes | Q34729450 |
| | Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system | Q34838060 |
| | Recent insights into the genetic basis of systemic lupus erythematosus | Q34980873 |
| | Triggers for anti-chromatin autoantibody production in SLE. | Q35045914 |
| | Transcriptional Factor PU.1 Regulates Decidual C1q Expression in Early Pregnancy in Human. | Q35087349 |
| | Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. | Q35227723 |
| | Molecular mechanisms for synchronized transcription of three complement C1q subunit genes in dendritic cells and macrophages | Q35266807 |
| | Autoantigenicity of nucleolar complexes. | Q35556338 |
| | The role of complement in the development of systemic lupus erythematosus | Q35698485 |
| | C1q and tumor necrosis factor superfamily: modularity and versatility | Q35885821 |
| | A protective role for innate immunity in systemic lupus erythematosus | Q35906102 |
| | C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins | Q36049951 |
| | Chromatographic resolution of the first component of human complement into three activities | Q36266154 |
| | The classical and regulatory functions of C1q in immunity and autoimmunity | Q36299455 |
| | Regulation of cytokine production during phagocytosis of apoptotic cells | Q36394974 |
| | Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors | Q36402594 |
| | Stem cells, ageing and the quest for immortality. | Q36523915 |
| | C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation | Q36541076 |
| | Genomic view of the evolution of the complement system. | Q36560366 |
| | Complement deficiencies in humans and animals: links to autoimmunity | Q36572977 |
| | The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. | Q36752476 |
| | The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. | Q36927866 |
| | The macrophage: past, present and future | Q36986722 |
| | A dramatic increase of C1q protein in the CNS during normal aging. | Q37093902 |
| | Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis | Q37246964 |
| | Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement | Q37339284 |
| | Complement activation and inhibition: a delicate balance. | Q37368654 |
| | Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR. | Q37496810 |
| | Clinical significance of complement deficiencies | Q37598280 |
| | Complement the cell death. | Q37603273 |
| | Cutaneous manifestations of complement deficiencies | Q37778649 |
| | Evolution of blood coagulation and fibrinolysis | Q37838990 |
| | Complement deficiency states and associated infections | Q37882132 |
| | CTRP family: linking immunity to metabolism | Q37977232 |
| | Regulation of complement protein biosynthesis in mononuclear phagocytes. | Q38164718 |
| | Clinical presentation of human C1q deficiency: How much of a lupus? | Q38407945 |
| | Inflammatory cascades mediate synapse elimination in spinal cord compression. | Q38617047 |
| | Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains | Q39654001 |
| | Activation and control of the complement system | Q39761363 |
| | Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation | Q39980543 |
| | Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin | Q40030966 |
| | Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain | Q40306336 |
| | Complement protein C1q forms a complex with cytotoxic prion protein oligomers | Q41048016 |
| | Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor | Q41160601 |
| | Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes | Q41645497 |
| | The human c1q globular domain: structure and recognition of non-immune self ligands | Q42113914 |
| | Subunit composition and structure of subcomponent C1q of the first component of human complement | Q42917134 |
| | Mannose-binding lectin engagement with late apoptotic and necrotic cells | Q44600225 |
| | Complement facilitates early prion pathogenesis | Q48930440 |
| | Systemic lupus erythematosus. | Q53495545 |
| | The phylogeny of the complement system and the origins of the classical pathway. | Q53569256 |
| | Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. | Q54014234 |
| | The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection | Q57415587 |
| | Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s | Q67290039 |
| | Proteolysis of the heavy chain of major histocompatibility complex class I antigens by complement component C1s | Q67654476 |
| | Evolution of the complement system | Q67788520 |
| | Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment | Q67918972 |
| | Discovery of the LE cell and its morphology | Q70119034 |
| | Antibodies to Polynucleotides: Distribution in Human Serums | Q71262055 |
| | Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. Introduction | Q72683915 |
| | C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited | Q73326011 |
| | [Absorption of L. E. factor by isolated cell nuclei] | Q73560726 |
| | Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG | Q73910753 |
| | [Systemic lupus erythematosus preceded by false-positive serologic tests for syphilis: presentation of five cases] | Q73949259 |
| | The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium | Q74303796 |
| | Mechanism of immune hemolysis: recognition of two steps in the conversion of EAC' 1,4,2 to E | Q74765038 |
| P921 | main subject | proteolysis | Q33123 |
| P304 | page(s) | 592 | |
| P577 | publication date | 2017-05-24 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions | |
| P478 | volume | 8 | |